Article 1
Annex XVII to Regulation (EC) No 1907/2006 is amended in accordance with the Annex.
Commission Regulation (EU) 2018/675 of 2 May 2018 amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances (Text with EEA relevance. )
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Annex XVII to Regulation (EC) No 1907/2006 is amended in accordance with the Annex.
1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2. It shall apply from 1 December 2018 except that, to the extent that paragraph 2 of the Annex applies to the substance ‘formaldehyde … %’, that paragraph shall apply from the date of entry into force.
ANNEX Annex XVII to Regulation (EC) No 1907/2006 is amended as follows: (1) Column 1 of entries 28 to 30 is replaced by the following: ‘28. Substances which are classified as carcinogen category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 1 or Appendix 2, respectively. 29. Substances which are classified as germ cell mutagen category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 3 or Appendix 4, respectively. 30. Substances which are classified as reproductive toxicant category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 5 or Appendix 6, respectively.’ (2) In Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein: ‘2,3-epoxypropyl methacrylate; glycidyl methacrylate 607-123-00-4 203-441-9 106-91-2 cadmium carbonate 048-012-00-5 208-168-9 513-78-0 cadmium hydroxide; cadmium dihydroxide 048-013-00-0 244-168-5 21041-95-2 cadmium nitrate; cadmium dinitrate 048-014-00-6 233-710-6 10325-94-7 formaldehyde … % 605-001-00-5 200-001-8 50-00-0 anthraquinone 606-151-00-4 201-549-0 84-65-1 N,N′-methylenedimorpholine; N,N′-methylenebismorpholine; [formaldehyde released from N,N′-methylenebismorpholine]; [MBM] 607-721-00-5 227-062-3 5625-90-1 reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2); [formaldehyde released from 3,3′-methylenebis[5-methyloxazolidine]; formaldehyde released from oxazolidin]; [MBO] 612-290-00-1 — — reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1); [formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT] 612-291-00-7 — — methylhydrazine 612-292-00-2 200-471-4 60-34-4’ (3) In Appendix 4, the following entries are inserted in the table in order of the index numbers set out therein: ‘cadmium carbonate 048-012-00-5 208-168-9 513-78-0 cadmium hydroxide; cadmium dihydroxide 048-013-00-0 244-168-5 21041-95-2 cadmium nitrate; cadmium dinitrate 048-014-00-6 233-710-6 10325-94-7’ (4) In Appendix 6, the following entries are inserted in the table in order of the index numbers set out therein: ‘2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one 606-041-00-6 400-600-6 71868-10-5 2,3-epoxypropyl methacrylate; glycidyl methacrylate 607-123-00-4 203-441-9 106-91-2 cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol 650-032-00-X — 94361-06-5 dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)]stannane 050-030-00-3 201-039-8 77-58-7 nonadecafluorodecanoic acid; [1] ammonium nonadecafluorodecanoate; [2] sodium nonadecafluorodecanoate [3] 607-720-00-X 206-400-3 [1] 221-470-5 [2] [3] 335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3] triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol 613-322-00-7 259-537-6 55219-65-3 quinolin-8-ol; 8-hydroxyquinoline 613-324-00-8 205-711-1 148-24-3 thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide 613-325-00-3 — 111988-49-9 carbetamide (ISO); (R)-1-(ethylcarbamoyl)ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate 616-223-00-7 240-286-6 16118-49-3’
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.